Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Narrative (Details) - Focused Company Plan [Member] $ in Millions |
9 Months Ended |
|---|---|
|
Oct. 02, 2022
USD ($)
| |
| Restructuring Cost and Reserve [Line Items] | |
| Restructuring cost incurred to date | $ 2,800 |
| Biopharma [Member] | |
| Restructuring Cost and Reserve [Line Items] | |
| Restructuring cost incurred to date | 1,100 |
| Restructuring charges incurred to date | 862 |
| Corporate Enabling Functions [Member] | |
| Restructuring Cost and Reserve [Line Items] | |
| Expected restructuring cost | 1,800 |
| Go-to Market Model [Member] | |
| Restructuring Cost and Reserve [Line Items] | |
| Expected restructuring cost | 1,400 |
| Manufacturing Optimization [Member] | |
| Restructuring Cost and Reserve [Line Items] | |
| Expected restructuring cost | $ 800 |
| Percentage of expected costs to be non-cash | 25.00% |